市場調查報告書
商品編碼
1105711
黃曲霉毒中毒療法的全球市場規模:按療法和地區劃分的預測(2022-2028 年)Global Aflatoxicosis Treatment Market Size study, By Treatment, and Regional Forecasts 2022-2028 |
全球黃曲霉毒中毒治療市場規模受到食源性疾病流行、對黃曲霉毒素認識的提高、有利的政府機構舉措和不斷增加的資助活動以及新興經濟體的推動。例如,通過增加食品貿易
另一方面,新興市場缺乏基礎設施和資源可能會阻礙這些市場在預測期內的增長。
本報告審視了全球黃曲霉毒素治療市場,並提供了全面的信息,包括市場概況、市場分析、治療和地區分析以及競爭格局。
Global Aflatoxicosis Treatment Market is valued approximately USD XX million in 2021 and is anticipated to grow with a healthy growth rate of more than XX % over the forecast period 2022-2028. Aflatoxicosis is a disease caused by aflatoxin consumption and acute aflatoxicosis. Aflatoxin toxicity found in both humans and animals. Aflatoxins are a family of toxins produced by certain fungi that are found on different agricultural crops such as maize, peanuts, cottonseed, and tree nuts. The main fungi that produce aflatoxins are Aspergillus flavus and Aspergillus parasiticus, which grow in warm and humid regions. Aflatoxin exposure cause various side effects including nausea, vomiting, abdominal pain, convulsions acutely. The growing prevalence of food borne diseases and increasing awareness towards aflatoxins as well as favorable initiatives from government authorities are factors that are accelerating the global market demand. For instance, according to World health Organization (WHO) - as of 2022, globally around 600 million people fall ill after eating contaminated food and 420 000 lost their lives every year. In low- and middle-income countries every year USD 110 billion spent on productivity and medical expenses due to contamination of food. Moreover, favorable initiatives from government authorities would influence the growth of Aflatoxicosis Treatment Market. For instance, April 2019 - U.S. Agency for International Development (USAID)'s Feed the Future Malawi Improved Seed Systems and Technologies (MISST) project handed over the Aflatoxin Testing Laboratory at Chitedze Research Station to the Government of Malawi (GoM). Along with this handover the participants launched two Aflasafe biocontrol products, named Aflasafe MW-MZ01 and Aflasafe MW02 to reduce risk of aflatoxins during crop production and post-harvest. If applied properly, the products can reduce aflatoxins during both crop production and post-harvest. Also, growing number of funding activates from government authorities coupled with increasing food trade in developing countries are anticipated to act as a catalyzing factor for the market demand during the forecast period. However, a lack of infrastructure, and resources in developing regions impede the growth of the market over the forecast period of 2022-2028.
The key regions considered for the global Aflatoxicosis Treatment Market study include Asia Pacific, North America, Europe, Latin America, and the Rest of the World. North America is the leading region across the world in terms of market share owing to the growing concern over food safety and contamination and presence of leading market players in the region. Whereas, Asia pacific is anticipated to exhibit a significant growth rate over the forecast period 2022-2028. Factors such as the growing incidences of post-harvest crop loss and funding activities from government authorities in the region, would create lucrative growth prospects for the global Aflatoxicosis Treatment Market across the Asia pacific region.
Major market players included in this report are:
Abbott Laboratories
AbbVie Inc.
AstraZeneca
F. Hoffmann-La Roche Ltd
GlaxoSmithKline plc.
Johnson & Johnson Services, Inc.
Merck & Co.
Pfizer Inc.
Sanofi
Zydus Cadilla
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Treatment:
Aflatoxicosis Treatment by Blood Transfusion
Aflatoxicosis Treatment by Oxygen Therapy
Aflatoxicosis Treatment by Antibiotics
Aflatoxicosis Treatment by Antihistamines
Aflatoxicosis Treatment by Immunosuppressants
Aflatoxicosis Treatment by Others
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World
Furthermore, years considered for the study are as follows:
Historical year - 2018, 2019, 2020
Base year - 2021
Forecast period - 2022 to 2028
Target Audience of the Global Aflatoxicosis Treatment Market in Market Study:
Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors
List of figures